MeSH term
Frequency | Condition_Probility | Aged | 12 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Female | 17 | 0.0 |
Humans | 52 | 0.0 |
Male | 18 | 0.0 |
Middle Aged | 14 | 0.0 |
RNA, Messenger/metabolism | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 12 | 0.0 |
Telomerase/metabolism | 2 | 3.0 |
*Telomere-Binding Proteins | 2 | 25.0 |
Telomeric Repeat Binding Protein 1 | 4 | 40.0 |
Amino Acid Sequence | 7 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Models, Biological | 3 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Telomerase/*metabolism | 7 | 15.0 |
Comparative Study | 5 | 0.0 |
Gene Expression | 3 | 0.0 |
Telomeric Repeat Binding Protein 2 | 2 | 20.0 |
English Abstract | 3 | 0.0 |
Base Sequence | 6 | 0.0 |
Cell Line | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Drug Resistance, Multiple | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
RNA/metabolism | 3 | 0.0 |
Stomach Neoplasms/*enzymology | 2 | 18.0 |
Carrier Proteins/biosynthesis/genetics | 2 | 5.0 |
*Drug Resistance, Neoplasm | 2 | 1.0 |
Gene Expression Regulation, Neoplastic | 6 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 15 | 0.0 |
Animals | 18 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Genes, Tumor Suppressor | 4 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mice | 11 | 0.0 |
Mutation | 3 | 0.0 |
*Tumor Suppressor Proteins | 16 | 1.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Rats | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Vault Ribonucleoprotein Particles/*metabolism | 2 | 28.0 |
Phosphoric Monoester Hydrolases/*genetics | 6 | 2.0 |
Adolescent | 3 | 0.0 |
Adult | 7 | 0.0 |
HL-60 Cells | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Monocytes/metabolism | 2 | 0.0 |
U937 Cells | 2 | 0.0 |
Cryoelectron Microscopy | 2 | 12.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
*RNA | 9 | 28.0 |
Telomerase/*biosynthesis/genetics | 2 | 33.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
*Genes, Tumor Suppressor | 4 | 0.0 |
Mutagenesis | 2 | 0.0 |
*Catalytic Domain | 2 | 14.0 |
Prognosis | 2 | 0.0 |
RNA-Directed DNA Polymerase/genetics/metabolism | 2 | 66.0 |
Survival Analysis | 3 | 0.0 |
Telomerase/*genetics/*metabolism | 4 | 33.0 |
Blotting, Northern | 2 | 0.0 |
G1 Phase/physiology | 3 | 4.0 |
Gene Expression Regulation, Neoplastic/physiology | 2 | 1.0 |
*Glioma | 3 | 37.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Telomerase/*analysis/genetics | 2 | 40.0 |
Telomerase/*genetics/metabolism | 2 | 10.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
Cell Division/genetics | 4 | 1.0 |
Cell Line, Transformed | 2 | 0.0 |
Phosphorylation | 4 | 0.0 |
Astrocytes/chemistry/*cytology | 2 | 50.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Extracellular Matrix Proteins/pharmacology | 2 | 22.0 |
Genes, Tumor Suppressor/physiology | 2 | 4.0 |
Glial Fibrillary Acidic Protein/analysis | 2 | 1.0 |
Plasmids | 2 | 0.0 |
Tumor Cells, Cultured/cytology/physiology | 2 | 16.0 |
Hela Cells | 4 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Chromosomes, Human, Pair 10 | 2 | 1.0 |
Phosphoric Monoester Hydrolases/genetics/*physiology | 2 | 6.0 |
Cell Division/drug effects | 2 | 0.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Telomerase/*chemistry | 2 | 100.0 |
*Phosphoric Monoester Hydrolases | 4 | 8.0 |
Protein-Tyrosine-Phosphatase/*genetics | 3 | 2.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Polymorphism, Genetic | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
In Vitro | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
